Thus, a comprehensive understanding of the expression profile and biological responses headed by RAGE in ER-positive BC might provide valuable benefits for the assessment of novel therapeutic approaches halting tumor progression, particularly in obese and/or diabetic patients. This evidence concerns the gene AGER and breast cancer.